Resources

January 18, 2018

Biosimilars – A year in Review

Thursday, January 18th, 2018, 1:00 pm EST

The biologics and biosimilars markets evolved rapidly in 2017. Life sciences attorneys John AdkissonTasha Francis, and Jenny Shmuel reviewed the U.S. market for biosimilar products and provided insights into:

  • Holdings and implications of:
    • This year’s Amgen v. Sandoz opinion from the Supreme Court;
    • Select District Court cases; and
    • Recent Federal Circuit cases of note, including:
      • Amgen v. Hospira
      • Amgen v. Apotex
      • Amgen v. Sandoz (remand)
  • Which biosimilars have been approved and launched.
  • Recent trends in IPR filings in the biosimilars space.
  • Statistics regarding the number of biosimilar applications under review by the FDA, and the average time to approval.

This complimentary webinar is designed for individuals who are interested in life sciences, pharmaceutical, and biosimilars legal issues.

To download the PDF slides of this presentation, click here.

If you have questions, please contact Jane Lundberg at lundberg@fr.com.

Speakers:

John Adkisson, Principal, Twin Cities
Tasha Francis, Associate, Twin Cities
Jenny Shmuel, Associate, Boston




No Comments

Sorry, the comment form is closed at this time.

Fill out the form below to receive our monthly newsletter and updates on your selected areas of interest. You can unsubscribe at any time by clicking the unsubscribe link at the bottom of the email.

  • This field is for validation purposes and should be left unchanged.